Table III.
Descriptive Statistics and Relations of Medical Variables with the BSID-II in Children with Cancer
|
r |
|||
|---|---|---|---|
| M (SD) | BSID-II Motor | BSID-II Mental | |
| Age at diagnosis | 18.99 (11.19) | .13 | .14 |
| Karnofsky at diagnosisa | 68.39 (14.11) | .42** | .30* |
| Risk (% high risk) at diagnosisb | 59% | −.06 | .13 |
| Illness status (% partial/no remission) at the assessmentb | 33% | .15 | .10 |
| Days of hospitalization | 46.92 (25.87) | −.10 | .10 |
| Presence of neuropathyb | 37% | −.02 | .11 |
| Child status at the assessmentc | 1.52 (0.60) | −.26 | −.24 |
| Child status 1 week before assessmentc | 2.07 (1.03) | −.22 | −.21 |
| Child status 1 month before assessmentc | 2.20 (0.95) | −.41** | −.30* |
| Child status, cumulative over last monthc | 1.92 (0.58) | −.45*** | −.41** |
| Treatment drugs | |||
| PDNb,d | 51% | −.14 | −.20 |
| DEXAb,d | 14% | −.22 | −.13 |
| VCRb,d | 69% | −.20 | −.25 |
| IT MTXb,d | 56% | −.09 | −.24 |
Note. ns = 53–57. All correlations controlled for child age at assessment, and child status also controlled for mother social desirability bias. aRange = 0 (Dead)–100 (Normal; no evidence of disease); A score ≥ 80 indicates the ability to carry on normal activity. brpb. cRange = 1–5. dPercent of children who were administered the drug.
*p < .05. **p < .01. ***p < .001.